Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)

The "Investigator-Initiated Research in Genomics and Health Equity" grant (R01 Clinical Trial Optional) intends to support and fund original research in the fields of genomics and health equality. The primary objective is to craft innovative approaches, generate and share knowledge, and create or apply measures or interventions that can promote equal genomic healthcare for all demographics within the US.

Grant recipients will conduct groundbreaking and broadly applicable research in genomics and health equity. Such research will encompass numerous scientific areas covered by the National Human Genome Research Institute (NHGRI). Furthermore, recipients will need to incorporate a strategy for including a broad range of perceptions and insights from diverse backgrounds.

This initiative highly encourages applications from New or Early Stage Investigators from underrepresented or diverse groups, as it strongly believes in a comprehensive and inclusive scope of research.